Previous 10 |
UroGen Pharma (URGN) Q4 2018 Earnings Conference Call February 28, 2019 8:30 A.M. ET Company Participants Kate Bechtold - Director, Corporate Communications and Investor Relations Liz Barrett - President and Chief Executive Officer Mark Schoenberg - Chief Medical Officer Peter ...
UroGen Pharma (NASDAQ: URGN ): Q4 GAAP EPS of -$1.46 misses by $0.27. More news on: UroGen Pharma, Earnings news and commentary, Healthcare stocks news, Read more ...
On Track to Complete UGN-101 Rolling NDA Submission to the FDA in 2H 2019 Acceleration of Pre-Commercial Activities and Infrastructure Buildout Underway to Support the Potential U.S. Approval and Launch of UGN-101 in 1H 2020 Initial Data from UGN-102 Trial Anticipated in 2019 ...
Conference Call and Webcast Scheduled for 8:30 AM ET UroGen Pharma Ltd. (Nasdaq:URGN) today announced that it will report fourth quarter and full year 2018 financial results on Thursday, February 28, 2019, prior to the open of the market. The announcement will be followed by a live au...
Quick Take Anchiano Therapeutics ( ANCN ) intends to raise $35 million in a U.S. IPO, per an amended regulatory filing . The company is developing a single biologic candidate to treat bladder and other cancers. ANCN has had promising trial results, strong existing investor support of th...
UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with a focus on uro-oncology, today announced the closing of its previously announced public offering of 4,207,317 ordinary shares, including 548...
SPI Energy (NASDAQ: SPI ) -13% . More news on: SPI Energy Co., Ltd., McCormick & Company, Inc., Wave Life Sciences, Stocks on the move, , Read more ...
UroGen Pharma (NASDAQ: URGN ) has priced public offering of 3,658,537 ordinary shares at $41.00 per share, for gross proceeds of ~$150M. More news on: UroGen Pharma, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-15 04:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-25 07:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the pricing of an underwritten public offering of 5,000,000 ordinary shares at a price to the public of $17.50 per ord...